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Novelty and impact statements:  13 
We found evidence of a dose-response association between physical activity and overall 14 
endometrial cancer.The novelty include use of repeated measurements for physical activity 15 
and confounders combined with multiple imputation to address attrition, which is a particular 16 
problem in observational epidemiology. As a nationally representative cohort our study gave 17 
us an unique opportunity to calculate robust population attributable fractions. 22% of 18 
endometrial cancer could be avoided if women increase their physical activity level.  19 
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Abstract  52 
Few studies have investigated the association between endometrial cancer and physical 53 
activity (PA) using repeated measures of PA and different subtypes of endometrial cancer. 54 
We aimed to investigate the association between endometrial cancer and PA level at two 55 
points in time in women with different body mass index (BMI) profiles, and to calculate the 56 
population attributable fraction (PAF) of endometrial cancer for low PA levels.  57 
We included 82,759 women with complete information on PA at baseline in the Norwegian 58 
Women and Cancer Study; 52,370 had follow-up information on PA. 687 endometrial cancer 59 
cases were identified. Multivariate cox proportional hazard models were used to estimate 60 
hazard ratios (HR) and 95% confidence intervals (CI). The PAF indicated the proportion of 61 
endometrial cancer that could be avoided in the population if these women had a higher PA 62 
level. 63 
There was a statistically significant association between low PA levels at baseline and follow-64 
up and endometrial cancer risk, with a dose-response trend (lowest PA level: HR=1.60, 95% 65 
CI 1.16-2.20; highest PA level: HR=0.73, 95% CI 0.45-1.16 compared to the median). 66 
Analyses that included follow-up measurements yielded similar results. 21.9% (95% CI 7.1-67 
34.3) of endometrial cancers could be avoided if women with low PA levels (≤ 4 in a 1-10 68 
degree self reported PA scale) increased their PA levels to 5-10.  69 
We found an inverse dose-response association between PA and endometrial cancer, 70 
independent of BMI. In this nationally representative cohort, 21.9% of endometrial cancers 71 
could potentially be avoided if PA levels increased to higher PA levels. 72 
73 
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Endometrial cancer is the sixth most common cancer, and the most frequent gynecologic 75 
malignancy among women in Norway. In 2014, 727 new cases were diagnosed and 81 76 
women died of the disease [1]. Established risk factors for endometrial cancer include use of 77 
exogenous estrogens unopposed by progestagens, early menarche (10-12 years of age), late 78 
menopause, nulliparity, diabetes mellitus, and obesity. Currently, the majority of endometrial 79 
cancer, and about half of the cases in postmenopausal women are attributable to being 80 
overweight or obese [2-4]. As the population ages and the prevalence of overweight, obesity, 81 
and sedentary lifestyle increase, the incidence of endometrial cancer is also expected to 82 
increase, especially in postmenopausal women [5, 6]. Thus primary prevention of endometrial 83 
cancer through modifiable lifestyle factors is of potential public health importance.  84 
Physical activity (PA) is a modifiable lifestyle factor, which is important in the regulation 85 
of hormones and metabolic pathways. It is also associated with weight control, and thus may 86 
reduce endometrial cancer risk [7-9]. A pooled analysis of nine cohorts from Europe and the 87 
United States included 1.44 million participants and found a 21% reduced risk of endometrial 88 
cancer associated with recreational PA [10] . However, within individual studies, results are 89 
inconsistent [8]. For example, the Women’s Health Study did not find any relationship 90 
between recreational PA and walking and endometrial cancer risk [11]. Similarly, there was 91 
no significant association between total PA – including occupational, recreational, and 92 
household-related PA – and endometrial cancer risk in the European Prospective Investigation 93 
into Nutrition and Cancer [12]. The 2007 evaluation by the World Cancer Research 94 
Fund/American Institute for Cancer Research (WCRF/AICR) concluded that there is a 95 
probable relationship between PA and endometrial cancer despite the variety of PA 96 
assessments not allowing for meta-analysis on dose-response [7]. This conclusion was 97 
supported in their Continous Update Project (CUP) report from 2013 [8]. Of four cohort 98 
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studies published  after the 2013 CUP report [10, 13-15], three found an inverse association 99 
between recreational PA and endometrial cancer risk [10, 15, 14], and one did not [13].  100 
Few studies have investigated the association between endometrial cancer and PA using a 101 
total and repeated measure of PA and different subtypes of endometrial cancer [12, 16, 17]. 102 
Endometrial cancer is classified as type I (estrogen dependent), which constitutes the majority 103 
of cases (about 80%), and type II (estrogen independent), based on clinical, endocrine, and 104 
epidemiological observations. The most common histological subtypes of endometrial cancer 105 
are endometrioid carcinoma, serous carcinoma, carcinosarcoma, and clear cell carcinoma 106 
[18].  While the association between body mass index (BMI) and endometrial cancer is well 107 
established, the relationship between PA and endometrial cancer in women with different 108 
body sizes remains unclear.  109 
The present study aimed to investigate the association between endometrial cancer and PA 110 
level at two points in time in women with different BMI profiles in the Norwegian Women 111 
and Cancer (NOWAC) Study, and to calculate the population attributable fraction (PAF) of 112 
endometrial cancer for low PA levels.  113 
 114 
  115 
Page 5 of 48
John Wiley & Sons, Inc.

































































The NOWAC Study 117 
The NOWAC Study is a nationally representative cohort study that has been described in 118 
detail previously [19, 20]. Briefly, random samples of Norwegian women aged 30-70 years 119 
were invited to participate during three waves of data collection (1991/92, 1996/97, and 120 
2003/04) [20]. More than 172,000 women completed a questionnaire with detailed questions 121 
regarding lifestyle, diet, and health, and were enrolled in the study (overall response rate: 122 
52.7%). The NOWAC Study was approved by the Regional Committee for Medical Research 123 
Ethics and the Norwegian Data Inspectorate, and all particpants included in the study gave 124 
written informed consent.  125 
In this analysis we used information from enrollment questionnaires completed in the 126 
period from 1996 to 2004 (baseline), and those with follow-up questionnaires completed 6-8 127 
years after enrollment.  In total 101,321 women completed questionnaires in these periods and 128 
were eligible for inclusion in this study. We excluded women with prevalent cancers other 129 
than non-melanoma skin cancer at baseline (n=4,454), those who emigrated or died before the 130 
start of follow-up (n=20), those with hysterectomy (n=5,426), and those who had missing 131 
information on PA level at baseline (n=8,662). Thus, the final analytical study sample 132 
consisted of 82,759 women. Follow-up information on PA level, smoking, weight, and height 133 
was available for for 52,370 (63.3%) of these women. 134 
 135 
Assessment of PA level and covariates 136 
PA level was assessed in the NOWAC questionnaires on a 10-point scale by the following 137 
question: “By physical activity we mean activity both at work and outside work, at home, as 138 
well as training/exercise and other physical activity, such as walking, etc. Please mark the 139 
number that best describes your level of physical activity; 1 being very low and 10 being very 140 
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high”. This PA scale has been validated [21] and refers to the total amount of PA across 141 
different domains, including recreation, occupation, transportation, and household in one 142 
global score. Moderate, but significant Spearman’s rank correlation coefficients were found 143 
(range: 0.36-0.46; P<0.001) between PA level at enrollment and concurrent outcomes from 144 
criterion measures of a combined sensor monitoring heart rate and movement. The PA scale 145 
appeared valid to rank PA level in Norwegian women, but not to quantify a definite dose of 146 
PA [21]. 147 
Information on the covariates height, weight, age at menarche, parity, oral contraceptive 148 
use, menopausal status, age at menopause, hormone therapy use, years of education, smoking 149 
status and alcohol consumption, were obtained from NOWAC questionnaires. The women 150 
were considered postmenopausal if they stated that the period had stopped or reported use of 151 
hormonal therapy if they were ≥53years. This cut-off point is based on the definition used in 152 
the the Million Women Study [22], and has been used by the NOWAC study earlier [23]. 153 
Information on height and weight was used to calculate BMI (kg/m
2
).  154 
 155 
Cancer incidence, death, and emigration 156 
Women diagnosed with a primary, invasive, malignant neoplasm of the endometrium 157 
(International Statistical Classification of Diseases, Injuries and Causes of Death Revision 7 158 
codes 172.0 [24]) were identified through linkage to the Cancer Registry of Norway, from 159 
which date of diagnosis and morphology (International Classification of Diseases for 160 
Oncology, 3
rd
 edition) were also obtained. Based on the morphology, endometrial cancers 161 
were categorized into overall endometrial cancer (all subtypes), endometrioid carcinoma, type 162 
1 endometrial cancer (adenocarcinoma NOS, endometrioid, and squamous carcinomas), and 163 
other subtypes (non-endometrioid or non-type 1).  164 
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Information on date of death or emigration was obtained through linkage to the 165 
Norwegian National Population Register.  166 
 167 
Statistical methods 168 
Analyses using baseline data only  169 
We used Cox proportional hazard regression models to calculate hazard ratios (HRs) with 170 
95% confidence intervals (CIs) comparing five categories of PA level (1-2, 3-4, 5-6, 7-8, and 171 
9-10). PA level 5-6 was set as the reference group. Follow-up time was defined as the interval 172 
between age at baseline and age at cancer diagnosis, death, emigration, or the end of follow-173 
up (31 December 2013), whichever came first.  174 
Departures from the proportional hazards assumption in the Cox models were tested through 175 
the inclusion of an interaction variable between categories of PA and underlying time (age). A 176 
preliminary analysis of baseline data only was used to select the covariates that were adjusted 177 
for in the final models. In the preliminary model, we adjusted for: height (in metres), BMI 178 
(normal weight: <25, overweight: 25–29.9, obese: ≥30 kg/m
2
), age at menarche (<12, 13-14, 179 
15+ years), parity (0, 1, 2, 3, 4+) , oral contraceptive use (ever/never), menopausal status 180 
(premenopausal, perimenopausal, postmenopausal, hormone therapy use ≥53 years), hormone 181 
therapy use (ever/never), years of education (≤9, >9-12, ≥13 years), smoking status (never, 182 
former, current), alcohol consumption (grams per day), and diabetes mellitus (yes/no). The 183 
removal of each covariate had to be associated with a change in the regression coefficients of 184 
at least 10% in any of the categories of PA level to be included in the final model. To test for 185 
linear trend, we used the original, 10-point PA scale, modelled as a continuous variable in the 186 
analyses. Interactions (log likelihood test) between PA and the above-mentioned categories of 187 
BMI, educational attainment and smoking status were tested. The Wald χ2 statistic was used 188 
to test for heterogeneity between normal weight and obese women.  189 
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Analyses using repeated PA measurements  192 
We used the method proposed by Hu et al [25], i.e., baseline data was used until follow-up 193 
information became available, death, or emigration, whichever occurred first. Thereafter 194 
follow-up information was applied until death, emigration, or the end of the study period, 195 
which ever occurred first. In the analysis using repeated PA measurements, we also used 196 
follow-up information on BMI and smoking once it became available.  197 
 198 
Complementary analysis - multiple imputation  199 
Compared to women who did not drop out of the study, those who dropped out of the study at 200 
follow-up (n=30,389 (36.7%)), were more often overweight (31.4% vs 29.2%) or obese 201 
(10.3% vs 8.6%), more often reported oral contraceptive use (46.6% vs 43.5%) and hormone 202 
therapy use (36.7% vs 31.7%), more often had a history of diabetes mellitus (2.9% vs 1.7%), 203 
and had fewer years of education (24.3% vs 23.7%). They were also more often current 204 
smokers, but on average they had a similar PA level and alcohol consumption as women who 205 
did not drop out of the study. In order to deal with dropouts, we used multiple imputation 206 
models [26] and compared the results with those of complete-case analyses. Multiple 207 
imputation models were used under the assumption that data was missing at random. To 208 
reduce sampling variability, we created 20 replicate datasets from the imputation simulation 209 
[27]. We used the outcomes overall endometrial cancer, type 1 endometrial cancer, and 210 
endometrioid carcinoma. Nelson-Aalen cumulative hazard estimator was included as a 211 
predictor in the imputation models [28]. The estimates from the 20 imputed datasets were 212 
combined using Rubin’s rules [29]. All the analyses and multiple imputations were done in 213 
STATA version 14.0 (Stata Corp, College Station, TX, USA). 214 
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PAF calculation 216 
We calculated the PAF to estimate the proportion of endometrial cancer that could be avoided 217 
in the population if women had different PA levels, using the formula: PAF= Pe*(RRe-218 
1)/[Pe*RR+(1-Pe)], where Pe is the proportion of PA level in the study population and RRe is 219 
the RR in the model adjusting for BMI (model 1) and the final baseline multivariable 220 
proportional hazards regression model (model 2), including all aforementioned confounders 221 
and BMI. We calculated two-sided 95% CIs for the PAFs using the PUNAF Stata module 222 
[30]. The PA levels were divided into two levels; levels 1 to 4 were classified as exposed to 223 
low PA levels and levels 5-10 as unexposed to low PA levels. The PAF was interpreted as the 224 
proportion of overall endometrial cancers that would not occur in the average population if 225 
PA levels were between 5 and 10 according to the scale. 226 
 227 
  228 
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The median age at baseline was 51 years. During a mean follow-up time of nearly 13 years, 230 
687 cases of endometrial cancer were identified, with type 1 endometrial cancer 231 
(adenocarcinoma not otherwise specified [NOS], endometrioid and squamous carcinoma) 232 
accounting for 83.8% of the cases. The age at diagnosis ranged between 42 and 86 years, with 233 
a mean of 62 years of age. Nearly half (43%) of the women reported a PA level between 5 234 
and 6 (Table 1), and approximately 74% of the women reported a PA level between 5 and 10. 235 
Women with a PA level >5 had a lower BMI, used less hormone therapy, reported less 236 
diabetes mellitus, and were more often never smokers compared to women reporting low PA 237 
levels.  238 
Multivariable models of the associations between baseline and one follow-up 239 
measurement of PA and endometrial cancer risk showes that compared to women with a PA 240 
level of 5-6, those with a PA level of 1-2 had a 60% higher risk of overall endometrial cancer 241 
(HR=1.60, 95% CI 1.16-2.20). For analyses using repeated PA measurements, the 242 
corresponding risks adjusted for BMI and smoking status were similar to those obtained when 243 
using baseline data only (HR=1.54, 95% CI 1.01-2.). In analyses using baseline data only and 244 
those using repeated PA measurments, BMI and smoking status were negatively associated 245 
with the risk of type 1 endometrial cancer and endometroid carcinomas. Compared to the age-246 
adjusted models, the associations were attenuated in the multivariable adjusted models that 247 
included BMI (Table 2).  248 
Interactions between PA and categories of BMI, educational attainment and smoking 249 
status were not significant. However, as BMI is a strong risk factor for endometrial cancer, we 250 
decided to investigate the association between PA and endometrial cancer risk in normal 251 
weight, overweight, and obese women, even though the interaction term was not significant 252 
(p=0.49).When analyses were stratified by BMI category the PA levels 7-10 were collapsed, 253 
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PA was not associated with overall endometrial cancer among normal-weight women in 254 
analyses using baseline data only (HRPA(1-2) vs (5-6) =1.32, 95% CI 0.71-2.45). The 255 
corresponding association in obese participants was HR PA(1-2) vs (5-6)=3.08 (95% CI 1.76-5.39) 256 
(pheterogeneity=0.05) (Table 3).  257 
Using multiple imputation, we found that the estimates at all levels of adjustment and for 258 
all endpoints (overall endometrial cancer, type 1 endometrial cancer, and endometrioid 259 
carcinoma) were consistent with those obtained from the complete-case analyses (Table 4). 260 
PAF calculations showed that if women with a PA level ≤4 increased to levels 5-10 in the 261 
scale, 21.9% (95% CI: 7.1-34.3) of endometrial cancers could be avoided (Table 5). PAF 262 
calculations based on the proportional hazards regression model including BMI yielded a 263 
lower proportion (17%, 95% CI: 2.3-29.5) (Table 5). The results did not differ substantially 264 
for subtypes of endometrial cancer (Supplemental table 1)       265 
 266 
Discussion 267 
In this large Norwegian cohort we found an inverse dose-response association between PA 268 
and endometrial cancer overall, type 1 endometrial cancer, and endometrioid carcinoma. The 269 
results were consistent when using baseline data on PA and when using repeated PA 270 
measurements, as well as when multiple imputation was used. Our findings further suggest 271 
that the association between PA and endometrial cancer is independent of BMI, as risk 272 
estimates were attenuated, but still significant, when BMI was incorporated in the statistical 273 
models. Stratification by BMI category indicated that the risk of low PA on endometrial 274 
cancer was statistically significant among obese women only (although the test for interaction 275 
was not statistically significant, p=0.49). Among women with PA levels ≤4, 21.9% of 276 
endometrial cancer could potentially be avoided if these women adopted a PA level between 277 
5-10 in the scale. 278 
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Other cohort studies investigating the association between total PA levels – which include 279 
domains such as recreation, occupation, transportation, and household – and endometrial 280 
cancer are sparse; most studies measured recreational PA only and few studies use repeated 281 
measurements of PA. In contrast to our results, the European Prospective Investigation into 282 
nutrition and Cancer reported a non-significant trend (p-trend 0.36) for total PA (including the 283 
domains recreation, occupation, and household) when comparing active with inactive women 284 
(multivariable adjusted model including BMI: HR=0.88, 95% CI 0.61-1.27) [12]. This was 285 
similar for the Breast Cancer Detection Demonstration Project study, which measured the 286 
total intensity of PA and found no significant associations with endometrial cancer [31]. 287 
Findings from the Netherlands Cohort Study on Diet and Cancer showed that total baseline 288 
non-occupational PA was inversely associated with endometrial cancer, with a lower risk 289 
observed for a PA corresponding to >30 minutes per day [17, 32]. In a Swedish cohort the 290 
risk was decreased, although this decrease was not significant [16].  291 
Several studies have reported on recreational PA and endometrial cancer. Nine 292 
prospective cohort studies on recreational PA were included in the WCRF/AICR CUP report 293 
up to 2012 [8], but due to different measures of PA, the meta-analysis of these studies only 294 
looked at the highest vs lowest PA level (RR=0.73, 95% CI 0.58-0.93), and these results were 295 
attenuated when the model was adjusted for BMI (RR=0.80, 95% CI 0.69-0.92). A limitation 296 
of this meta-analysis was the high heterogeneity (I
2
=75.9%) of the individual studies [8]. 297 
Indeed, only three of these studies [33, 32, 34] found significant inverse associations, three 298 
found no significant association [35, 11, 36], and three [37, 12, 16] found an inverse, but 299 
insignificant association between endometrial cancer and recreational PA. Since the 300 
publication of the WCRF/AICR CUP report from 2012 we have identified four additional 301 
prospective cohort studies on recreational PA and endometrial cancer [10, 13-15]. The 302 
Nurses’ Health study investigated recreational PA in the past year and found no association 303 
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between baseline recreational PA and endometrial cancer risk, however, brisk walking time 304 
≥3 hours per week was inversely associated with endometrial cancer [15]. In the California 305 
Teachers Study cohort, moderate and vigorous recreational PA was associated with a 25% 306 
lower endometrial cancer risk [13]. The findings of Land et al [14] are in accordance with our 307 
findings, although they studied recreational PA and had a small number of cases in a 308 
population of women at high risk for breast cancer. A large pooled analysis of 12 cohorts was 309 
recently published and reported a HR of 0.79 (95% CI 0.68-0.92) in the association between 310 
recreational PA and endometrial cancer based on 5346 cases. However, the degree of 311 
heterogeneity between cohorts was high (I
2
=69%)[10] .  312 
Analysis of occupational PA measured twice during 1974 and 1981 in a Norwegian study 313 
showed a significant trend, with a reduced risk for women who were consistently moderately 314 
active; however, the association was attenuated in the multivariable model and the trend was 315 
no longer significant [36]. The WCRF/AICR CUP report [8] included four cohort studies [16, 316 
38, 12, 39], none of which found a significant association between occupational PA and 317 
endometrial cancer. In a highest vs lowest occupational PA meta-analysis, the summary RR 318 
was 0.79 (95% CI 0.71-0.88), with a high degree of heterogeneity between studies (I
2
= 319 
75.9%) and concluded a probable inverse association between occupational PA and 320 
endometrial cancer [8].  321 
Overweight and obesity are strong risk factors for endometrial cancer, and studies suggest 322 
that the association between PA and endometrial cancer is either mediated or confounded by 323 
body weight, which can affect hormone profiles. Therefore, it is important to model the 324 
association both with and without adjustment for BMI [15].  In our study, adjustment for BMI 325 
in the multivariable analyses attenuated the associations. However, a modest inverse 326 
association remained, suggesting that PA is independently associated with endometrial 327 
cancer. Simultanously, the analyses of the different BMI categories showed that the 328 
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association was more pronounced in obese than in normal-weight women. In our data, obesity 329 
may confound the association between PA and overall endometrial cancer. Our findings are in 330 
accordance with Friberg et al [16]. However, Moore et al adjusted for BMI in the association 331 
between recreational PA and endometrial cancer and showed an attenuation of the estimates 332 
from a significant towards a non-significant result compared to multivariable models 333 
unadjusted for BMI (HR=0.98, 95% CI 0.89-1.09 vs HR=0.79, 95% CI 0.68-0.92) . This was 334 
similar to several previous studies [14, 15, 33, 37]. Some studies have found a statistically 335 
significant increased endometrial cancer risk in both inactive and active overweight women 336 
[11], which correspond to our findings. Others have shown an effect modification, where the 337 
inverse relationship was only seen among overweight or obese women [10, 37]. As in our 338 
study, several other studies have reported no significant effect modification for BMI [33, 12, 339 
16, 17, 31].  340 
Heterogeneity in different study results may be explained by variations in the methods 341 
used to assess PA (self-adminstered questionnaires, interviews, or use of job titles); PA 342 
domains (recreation, occupation, transportation, household); frequency, duration, and 343 
intensity of PA; and time periods in life when PA was measured, as well as different statistical 344 
methods used in the data analysis [40]. Nevertheless, there is substantial biological evidence 345 
to support a potential protective role of PA on endometrial cancer. The mechanisms involved 346 
have been hypothesized as affecting endogenous sex hormone levels, insulin-mediated 347 
pathways, and maintenance of energy balance [41]. 348 
Physical inactivity is considered an important risk factor for different cancers [42-44]. The 349 
consistent associations between low PA levels and endometrial cancer risk  in our study 350 
justify the estimation of PAFs. Our definition of low PA levels was based on self-reported PA 351 
using a validated 10-point scale [21]. Our PAF estimation represents the minimum move 352 
required from low to higher levels of PA to create a significant change in the incidence of 353 
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endometrial cancer (21.9%, 95% CI: 7.1-34.3). However, the definite dose cannot be 354 
quantified and our results must be interpreted with caution. In the UK, Parkin found a PAF for 355 
endometrial cancer of 3.8% attributable to exercising less than the minimum recommended 356 
amount [43]. The proportion related to inadequate PA in the UK in 2002 was 30% for 357 
endometrial cancer, however that compared the highest (≥60 minutes) and lowest (<30 358 
minutes) PA levels, which gives a higher reference category than the recommendation of PA 359 
[45]. To quantify the PAF requires a realistic population distribution of the exposure of 360 
interest, which in our study is PA. We consider our cohort to be a nationally respresentative 361 
Norwegian cohort with a reliable population distribution of PA, and as such it should give a 362 
robust estimate. Furthermore, it is valuable to evaluate the impact of different factors in 363 
cancer prevention, which is helpful in prioritizing cancer prevention and intervention 364 
strategies.   365 
A major strength of our study is its prospective, population-based design, and the use of a 366 
high-quality, national cancer registry to identify endometrial cancer cases [20]. The large 367 
sample size and representativeness of the Norwegian female population 30 to 70 years of age 368 
gives a unique opportunity to calculate robust PAF estimates. The PA scale has been validated 369 
[21] and correlated well with all-cause mortality rates [46]. Furthermore, PA level, BMI, and 370 
smoking were re-assessed at follow-up. Self-reported BMI has been validated for the 371 
NOWAC study, indicating that there was a substantial agreement between self-reported and 372 
measured BMI values [47]. There was, however, a small but statistically significant under-373 
reporting of weight, which would affect self-reported BMI; this tendency was largest among 374 
overweight and obese women [20, 47] . A survey of the PA levels in the adult population in 375 
Norway showed that 34% of women reached the national guidelines for PA [48]. This 376 
proportion is higher than in our study. The relatively large number of cases made it possible to 377 
investigate subtypes of endometrial cancer, however the proportion of type 2 endometrial 378 
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cancer was too low to allow for separate analyses. Multiple imputation of missing data, in 379 
addition to complete-case analysis, confirmed our results. The PA assessment in our study 380 
comprised all areas of PA, not only recreational PA. However, the total self-reported measure 381 
of PA cannot differentiate intensity, duration, and frequency of PA, nor the type of PA in our 382 
study, and given the self report of PA, measurement errors cannot be ruled out. However, 383 
measurement errors would likely lead to a non-differential bias and a potential 384 
underestimation of the true effect. The PA assessment used in this study may not apply to 385 
women in other countries.  Moreover, the potential for residual confounding, in particular by 386 
BMI, remains. 387 
 388 
Conclusions  389 
Overall, we found an inverse dose-response association between PA and endometrial cancer 390 
with similar findings for subtypes of endometrial cancer. This risk was higher in obese 391 
women. Also, 21.9% of the endometrial cancer cases could be attributable to low levels of 392 
PA, and could potentially be avoided if women attained a higher PA level. 393 
  394 
 395 
Ethical approval: All procedures performed in studies involving human participants were in 396 
accordance with the ethical standards of the institutional and/or national research committee 397 
and with the 1964 Helsinki declaration and its later amendments or comparable ethical 398 
standards.  399 
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Abstract  53 
Few studies have investigated the association between endometrial cancer and physical 54 
activity (PA) using repeated measures of PA and different subtypes of endometrial cancer. 55 
We aimed to investigate the association between endometrial cancer and PA level at two 56 
points in time in women with different body mass index (BMI) profiles, and to calculate the 57 
population attributable fraction (PAF) of endometrial cancer for low PA levels.  58 
We included 82,759 women with complete information on PA at baseline in the Norwegian 59 
Women and Cancer Study; 52,370 had follow-up information on PA. 687 endometrial cancer 60 
cases were identified. Multivariate cox proportional hazard models were used to estimate 61 
hazard ratios (HR) and 95% confidence intervals (CI). The PAF indicated the proportion of 62 
endometrial cancer that could be avoided in the population if these women had a higher PA 63 
level. corresponding to ≥150 minutes of moderate/vigorous PA per week. 64 
There was a statistically significant association between low PA levels at baseline and follow-65 
up and endometrial cancer risk, with a dose-response trend (lowest PA level: HR=1.8560, 66 
95% CI 1.1636-2.2053; highest PA level: HR=0.713, 95% CI 0.45-1.126 compared to the 67 
median). The Aanalyses that includedincluding  follow-up measurements yielded similar 68 
results. se associations were attenuated after adjustment for BMI, but remained significant. 69 
231.91% (95% CI 7.16--34.349) of endometrial cancers could be avoided if women with low 70 
PA levels (≤ 4 in a 1-10 degree self reported PA scale) increased their PA levels to 5-10.at 71 
least 150 minutes/week .  72 
We found an inverse dose-response association between PA and endometrial cancer, 73 
independent of BMI. In this nationally representative cohort, 21.9% One of four endometrial 74 
cancers could potentially be avoided if PA levels increased to higher PA levels (5-10 in the 75 
scale)150 minutes per week. 76 
77 
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Endometrial cancer is the sixth most common cancer, and the most frequent gynecologic 79 
malignancy among women in Norway. In 2014, 727 new cases were diagnosed and 81 80 
women died of the disease [1]. Established risk factors for endometrial cancer include use of 81 
exogenous estrogens unopposed by progestagens, early menarche (10-12 years of age), late 82 
menopause, nulliparity, diabetes mellitus, and obesity. Currently, the majority of endometrial 83 
cancer, and about half of the cases in postmenopausal women are attributable to being 84 
overweight or obese [2-4]. As the p pulation ages and the prevalence of overweight, obesity, 85 
and sedentary lifestyle increase, the incidence of endometrial cancer is also expected to 86 
increase, especially in postmenopausal women [5, 6]. Thus primary prevention of endometrial 87 
cancer through modifiable lifestyle factors is of potential public health importance.  88 
Physical activity (PA) is a modifiable lifestyle factor, which is important in the regulation 89 
of hormones and metabolic pathways. It is also associated with weight control, and thus may 90 
reduce endometrial cancer risk [7-9]. A pooled analysis of nine cohorts from Europe and the 91 
United States included 1.44 million participants and found a 21% reduced risk of endometrial 92 
cancer associated with recreational PA [10] . However, within individual studies, results are 93 
inconsistent [8]. For example, the Women’s Health Study did not find any relationship 94 
between recreational PA and walking and endometrial cancer risk [11]. Similarly, there was 95 
no significant association between total PA – including occupational, recreational, and 96 
household-related PA – and endometrial cancer risk in the European Prospective Investigation 97 
into Nutrition and Cancer [12]. The 2007 evaluation by the World Cancer Research 98 
Fund/American Institute for Cancer Research (WCRF/AICR) concluded that there is a 99 
probable relationship between PA and endometrial cancer despite the variety of PA 100 
assessments not allowing for meta-analysis on dose-response [7]. This conclusion was 101 
supported in their Continous Update Project (CUP) report from 2013 [8]. Of four cohort 102 
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studies published  after the 2013 CUP report [10, 13-15], three found an inverse association 103 
between recreational PA and endometrial cancer risk [10, 15, 14], and one did not [13].  104 
Few studies have investigated the association between endometrial cancer and PA using a 105 
total and repeated measure of PA and different subtypes of endometrial cancer [12, 16, 17]. 106 
Endometrial cancer is classified as type I (estrogen dependent), which constitutes the majority 107 
of cases (about 80%), and type II (estrogen independent), based on clinical, endocrine, and 108 
epidemiological observations. The most common histological subtypes of endometrial cancer 109 
are endometrioid carcinoma, serous carcinoma, carcinosarcoma, and clear cell carcinoma 110 
[18].  While the association between body mass index (BMI) and endometrial cancer is well 111 
established, the relationship between PA and endometrial cancer in women with different 112 
body sizes remains unclear.  113 
The present study aimed to investigate the association between endometrial cancer and PA 114 
level at two points in time in women with different BMI profiles in the Norwegian Women 115 
and Cancer (NOWAC) Study, and to calculate the population attributable fraction (PAF) of 116 
endometrial cancer for low PA levels.  117 
 118 
  119 
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The NOWAC Study 121 
The NOWAC Study is a nationally representative cohort study that has been described in 122 
detail previously [19, 20]. Briefly, random samples of Norwegian women aged 30-70 years 123 
were invited to participate during three waves of data collection (1991/92, 1996/97, and 124 
2003/04) [20]. More than 172,000 women completed a questionnaire with detailed questions 125 
regarding lifestyle, diet, and health, and were enrolled in the study (overall response rate: 126 
52.7%). The NOWAC Study was approved by the Regional Committee for Medical Research 127 
Ethics and the Norwegian Data Inspectorate, and all particpants included in the study gave 128 
written informed consent.  129 
In this analysis we used information from enrollment questionnaires completed in the 130 
period from 1996 to 2004 (baseline), and those with follow-up questionnaires completed 6-8 131 
years after enrollment.  In total 101,321 women completed questionnaires in these periods and 132 
were eligible for inclusion in this study. We excluded women with prevalent cancers other 133 
than non-melanoma skin cancer at baseline (n=4,454), those who emigrated or died before the 134 
start of follow-up (n=20), those with hysterectomy (n=5,426), and those who had missing 135 
information on PA level at baseline (n=8,662). Thus, the final analytical study sample 136 
consisted of 82,759 women. Follow-up information on PA level, smoking, weight, and height 137 
was available for for 52,370 (63.3%) of these women. 138 
 139 
Assessment of PA level and covariates 140 
PA level was assessed in the NOWAC questionnaires on a 10-point scale by the following 141 
question: “By physical activity we mean activity both at work and outside work, at home, as 142 
well as training/exercise and other physical activity, such as walking, etc. Please mark the 143 
number that best describes your level of physical activity; 1 being very low and 10 being very 144 
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high”. This PA scale has been validated [21] and refers to the total amount of PA across 145 
different domains, including recreation, occupation, transportation, and household in one 146 
global score. Moderate, but significant Spearman’s rank correlation coefficients were found 147 
(range: 0.36-0.46; P<0.001) between PA level at enrollment and concurrent outcomes from 148 
criterion measures of a combined sensor monitoring heart rate and movement. This 149 
corresponded to mean values of 0.8 (very low) and 3.4 hours per day (very high) of 150 
moderate/vigorous PA, respectively, with a linear increase (P for trend <0.001). The PA scale 151 
appeared valid to rank PA level in Norwegian women, but not to quantify a definite dose of 152 
PA [21]. 153 
Information on the covariates height, weight, age at menarche, parity, oral contraceptive 154 
use, menopausal status, age at menopause, hormone therapy use, years of education, smoking 155 
status and, alcohol consumption, were obtained from NOWAC questionnaires. The women 156 
wereas considered postmenopausal if they stated that the period had stopped or had a 157 
hysterectomy (excluded from the study) or reported use of hormonal therapy if they were 158 
≥53years. This cut-off point is based on the definition used in the the Million Women Study 159 
[22], and has been used by the NOWAC study earlier [23]. Information on height and weight 160 
was used to calculate BMI (kg/m2).  161 
 162 
Cancer incidence, death, and emigration 163 
Women diagnosed with a primary, invasive, malignant neoplasm of the endometrium 164 
(International Statistical Classification of Diseases, Injuries and Causes of Death Revisions 7 165 
and 10 codes 172.0  and C 54.1, respectively [24]) were identified through linkage to the 166 
Cancer Registry of Norway, from which date of diagnosis and morphology (International 167 
Classification of Diseases for Oncology, 3
rd
 edition) were also obtained. Based on the 168 
morphology, endometrial cancers were categorized into overall endometrial cancer (all 169 
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subtypes), endometrioid carcinoma, type 1 endometrial cancer (adenocarcinoma NOS, 170 
endometrioid, and squamous carcinomas), and other subtypes (non-endometrioid or non-type 171 
1).  172 
Information on date of death or emigration was obtained through linkage to the 173 
Norwegian National Population Register.  174 
 175 
Statistical methods 176 
Analyses using baseline data only  177 
We used Cox proportional hazard regression models to calculate hazard ratios (HRs) with 178 
95% confidence intervals (CIs) comparing five categories of PA level (1-2, 3-4, 5-6, 7-8, and 179 
9-10). PA level 5-6 was set as the reference group. Follow-up time was defined as the interval 180 
between age at baseline and age at cancer diagnosis, death, emigration, or the end of follow-181 
up (31 December 2013), whichever came first.  182 
Departures from the proportional hazards assumption in the Cox models were tested through 183 
the inclusion of an interaction variable between categories of PA and underlying time (age). A 184 
preliminary analysis of baseline data only was used to select the covariates that were adjusted 185 
for in the final models. In the preliminary model, we adjusted for: height (in metres), BMI 186 
(normal weight: <25, overweight: 25–29.9, obese: ≥30 kg/m
2
), age at menarche (<12, 13-14, 187 
15+ years), parity (0, 1, 2, 3, 4+) , oral contraceptive use (ever/never), menopausal status 188 
(premenopausal, perimenopausal, postmenopausal, hormone therapy use ≥<53 years), 189 
hormone therapy use (ever/never), years of education (≤9, >9-12, ≥13 years), smoking status 190 
(never, former, current), alcohol consumption (grams per day), and diabetes mellitus (yes/no). 191 
The removal of each covariate had to be associated with a change in the regression 192 
coefficients of at least 10% in any of the categories of PA level to be included in the final 193 
model. To test for linear trend, we used the original, 10-point PA scale, modelled as a 194 
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continuous variable in the analyses. Interactions (log likelihood test) between PA and the 195 
above-mentioned categories of BMI, educational attainment and smoking status were tested. 196 
The Wald χ2 statistic was used to test for heterogeneity between normal weight and obese 197 
women.not significant.  198 
As BMI is a strong risk factor for endometrial cancer, we decided to investigate the 199 
association between PA and endometrial cancer risk in normal weight, overweight, and obese 200 
women, even though the interaction term was not significant (p=0.49). The Wald χ2 statistic 201 
was used to test for heterogeneity between normal weight and obsese women. 202 
 203 
Analyses using repeated PA measurements  204 
We used the method proposed by Hu et al [25], i.e., baseline data was used until follow-up 205 
information became available, death, or emigration, whichever occurred first. Thereafter 206 
follow-up information was applied until death, emigration, or the end of the study period, 207 
which ever occurred first. In the analysis using repeated PA measurements, we also used 208 
follow-up information on BMI and smoking once it became available.  209 
 210 
Complementary analysis - multiple imputation  211 
Compared to women who did not drop out of the study, those who dropped out of the study at 212 
follow-up (n=30,389 (36.7%)), were more often overweight (31.4% vs 29.2%) or obese 213 
(10.3% vs 8.6%), more often reported oral contraceptive use (46.6% vs 43.5%) and hormone 214 
therapy use (36.7% vs 31.7%), more often had a history of diabetes mellitus (2.9% vs 1.7%), 215 
and had fewer years of education (24.3% vs 23.7%). They were also more often current 216 
smokers, but on average they had a similar PA level and alcohol consumption as women who 217 
did not drop out of the study. In order to deal with dropouts, we used multiple imputation 218 
models [26] and compared the results with those of complete-case analyses. Multiple 219 
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imputation models were used under the assumption that data was missing at random. To 220 
reduce sampling variability, we created 20 replicate datasets from the imputation simulation 221 
[27]. We used the outcomes overall endometrial cancer, type 1 endometrial cancer, and 222 
endometrioid carcinoma. Nelson-Aalen cumulative hazard estimator was included as a 223 
predictor in the imputation models [28]. The estimates from the 20 imputed datasets were 224 
combined using Rubin’s rules [29]. All the analyses and multiple imputations were done in 225 
STATA version 14.0 (Stata Corp, College Station, TX, USA). 226 
 227 
PAF calculation 228 
We calculated the PAF to estimate the proportion of endometrial cancer that could be avoided 229 
in the population if women had different PA levels, using the formula: PAF= Pe*(RRe-230 
1)/[Pe*RR+(1-Pe)], where Pe is the proportion of PA level in the study population and RRe is 231 
the RR in the model adjusting for BMI (model 1) and the final baseline multivariable 232 
proportional hazards regression model (model 2), including all aforementioned confounders 233 
and BMI. We calculated two-sided 95% CIs for the PAFs using the PUNAF Stata module 234 
[30]. The PA levels were divided into two levels; levels 1 to 4 were classified as exposed to 235 
low PA levels and levels 5-10 as unexposed to low PA levels. The PAF was interpreted as the 236 
proportion of overall endometrial cancers that would not occur in the average population if 237 
PA levels waswere between 5 and 10 according to the scale.≥ 8, corresponding to 150 minutes 238 
per week according to the validation of PA in NOWAC , assuming that the distribution of the 239 
adjustment variables remained unchanged. 240 
 241 
  242 
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The median age at baseline was 51 years. During a mean follow-up time of nearly 13 years, 244 
687 cases of endometrial cancer were identified, with type 1 endometrial cancer 245 
(adenocarcinoma not otherwise specified [NOS], endometrioid and squamous carcinoma) 246 
accounting for 83.8% of the cases. The age at diagnosis ranged between 42 and 86 years, with 247 
a mean of 62 years of age. Nearly half (43%) of the women reported a PA level between 5 248 
and 6 (Table 1), and collapsing the upper part of the scale showed that aApproximately 74% 249 
of the women reported a PA level between 5 and 10. with level ≥8 comprised 15% of the 250 
participants. Women with a PA level >5 had a lower BMI, used less hormone therapy, 251 
reported less diabetes mellitus, and were more often never smokers compared to women 252 
reporting low PA levels. (Table 1).  253 
Multivariable models of the associations between baseline and one follow-up 254 
measurement of PA and endometrial cancer risk showes that compared to women with a PA 255 
level of 5-6, those with a PA level of 1-2 had a 60% higher risk of overall endometrial cancer 256 
(HR=1.60, 95% CI 1.16-2.20). Removing BMI from the models increased these estimates 257 
(HR=1.85, 95% CI 1.36-2.36). For analyses using repeated PA measurements, the 258 
corresponding risks adjusted for BMI and smoking status were similar to those obtained when 259 
using baseline data only (HR with BMI adjustment=1.54, 95% CI 1.01-2.17 and HR without 260 
BMI adjustment=1.80, 95% CI 1.19-2.72). In analyses using baseline data only and those 261 
using repeated PA measurments, BMI and smoking status were negatively associated with the 262 
risk of type 1 endometrial cancer and endometroid carcinomasncers. Compared to the age-263 
adjusted models, the associations were attenuated in the multivariable adjusted models that 264 
included BMI (Table 2).  265 
Interactions between PA and categories of BMI, educational attainment and smoking 266 
status were not significant. However, aAs BMI is a strong risk factor for endometrial cancer, 267 
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we decided to investigate the association between PA and endometrial cancer risk in normal 268 
weight, overweight, and obese women, even though the interaction term was not significant 269 
(p=0.49).When analyses were stratified by BMI category the PA levels 7-10 were collapsed, 270 
PA was not associated with overall endometrial cancer among normal-weight women in 271 
analyses using baseline data only (HRPA(1-2) vs (5-6) =1.32, 95% CI 0.71-2.45). The 272 
corresponding association in obese participants was HR PA(1-2) vs (5-6)=3.08 (95% CI 1.76-5.39) 273 
(pheterogeneity=0.05) (Table 3).  274 
Using multiple imputation, we f und that the estimates at all levels of adjustment and for 275 
all endpoints (overall endometrial cance , type 1 endometrial cancer, and endometrioid 276 
carcinoma) were consistent with those obtained from the complete-case analyses (Table 4). 277 
(Supplemental Table 1). PAF calculations showed that if women with a PA level ≤4 increased 278 
to levels 5-10 in the scalethat level to ≥ 8, 21.931% (95% CI: 7.16-34.349) of endometrial 279 
cancers could be avoided (Table 5). PAF calculations based on the proportional hazards 280 
regression model including BMI yielded a lower proportion (17%, 95% CI: 2.3-29.5) (Table 281 
5). The results did not differ substantially for subtypes of endometrial cancer (Supplemental 282 
table 1)     (more than 1 in 4) (Supplementary Figure 1).  283 
 284 
Discussion 285 
In this large Norwegian cohort we found an inverse dose-response association between PA 286 
and endometrial cancer overall, type 1 endometrial cancer, and endometrioid carcinoma. The 287 
results were consistent when using baseline data on PA and when using repeated PA 288 
measurements, as well as when multiple imputation was used. Our findings further suggest 289 
that the association between PA and endometrial cancer is independent of BMI, as risk 290 
estimates were attenuated, but still significant, when BMI was incorporated in the statistical 291 
models. Stratification by BMI category indicated that the risk of low PA on endometrial 292 
cancer was statistically significant among obese women only (although the test for interaction 293 
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was not statistically significant, p=0.49). Among women with PA levels ≤4, 21.931% of 294 
endometrial cancer could potentially be avoided if these women adopted a PA level between 295 
5-10 in the scale≥8, which corresponds to approximately 150 minutes of moderate/vigorous 296 
PA per week. 297 
Other cohort studies investigating the association between total PA levels – which include 298 
domains such as recreation, occupation, transportation, and household – and endometrial 299 
cancer are sparse; most studies measured recreational PA only and few studies use repeated 300 
measurements of PA. In contrast to our results, the European Prospective Investigation into 301 
nutrition and Cancer reported a non-significant trend (p-trend 0.36) for total PA (including the 302 
domains recreation, occupation, and household) when comparing active with inactive women 303 
(multivariable adjusted model including BMI: HR=0.88, 95% CI 0.61-1.27) [12]. This was 304 
similar for the Breast Cancer Detection Demonstration Project study, which measured the 305 
total intensity of PA and found no significant associations with endometrial cancer [31]. 306 
Findings from the Netherlands Cohort Study on Diet and Cancer showed that total baseline 307 
non-occupational PA was inversely associated with endometrial cancer, with a lower risk 308 
observed for a PA corresponding to >30 minutes per day [17, 32]. In a Swedish cohort the 309 
risk was decreased, although this decrease was not significant [16].  310 
Several studies have reported on recreational PA and endometrial cancer. Nine 311 
prospective cohort studies on recreational PA were included in the WCRF/AICR CUP report 312 
up to 2012 [8], but due to different measures of PA, the meta-analysis of these studies only 313 
looked at the highest vs lowest PA level (RR=0.73, 95% CI 0.58-0.93), and these results were 314 
attenuated when the model was adjusted for BMI (RR=0.80, 95% CI 0.69-0.92). A limitation 315 
of this meta-analysis was the high heterogeneity (I2=75.9%) of the individual studies [8]. 316 
Indeed, only three of these studies [33, 32, 34] found significant inverse associations, three 317 
found no significant association [35, 11, 36], and three [37, 12, 16] found an inverse, but 318 
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insignificant association between endometrial cancer and recreational PA. Since the 319 
publication of the WCRF/AICR CUP report from 2012 we have identified four additional 320 
prospective cohort studies on recreational PA and endometrial cancer [10, 13-15]. The 321 
Nurses’ Health study investigated recreational PA in the past year and found no association 322 
between baseline recreational PA and endometrial cancer risk, however, brisk walking time 323 
≥3 hours per week was inversely associated with endometrial cancer [15]. In the California 324 
Teachers Study cohort, moderate and vigorous recreational PA was associated with a 25% 325 
lower endometrial cancer risk [13]. The findings of Land et al [14] are in accordance with our 326 
findings, although they studied recreational PA and had a small number of cases in a 327 
population of women at high risk for breast cancer. A large pooled analysis of 12 cohorts was 328 
recently published and reported a HR of 0.79 (95% CI 0.68-0.92) in the association between 329 
recreational PA and endometrial cancer based on 5346 cases. However, the degree of 330 
heterogeneity between cohorts was high (I
2
=69%)[10] .  331 
Analysis of occupational PA measured twice during 1974 and 1981 in a Norwegian study 332 
showed a significant trend, with a reduced risk for women who were consistently moderately 333 
active; however, the association was attenuated in the multivariable model and the trend was 334 
no longer significant [36]. The WCRF/AICR CUP report [8] included four cohort studies [16, 335 
38, 12, 39], none of which found a significant association between occupational PA and 336 
endometrial cancer. In a highest vs lowest occupational PA meta-analysis, the summary RR 337 
was 0.79 (95% CI 0.71-0.88), with a high degree of heterogeneity between studies (I
2
= 338 
75.9%) and concluded a probable inverse association between occupational PA and 339 
endometrial cancer [8].  340 
Overweight and obesity are strong risk factors for endometrial cancer, and studies suggest 341 
that the association between PA and endometrial cancer is either mediated or confounded by 342 
body weight, which can affect hormone profiles. Therefore, it is important to model the 343 
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association both with and without adjustment for BMI [15].  In our study, adjustment for BMI 344 
in the multivariable analyses attenuated the associations. However, a modest inverse 345 
association remained, suggesting that PA is independently associated with endometrial 346 
cancer. Simultanously, the analyses of the different BMI categories showed that the 347 
association was more pronounced in obese than in normal-weight women. In our data, obesity 348 
may confound the association between PA and overall endometrial cancer. Our findings are in 349 
accordance with Friberg et al [16]. However, Moore et al adjusted for BMI in the association 350 
between recreational PA and endometrial cancer and showed an attenuation of the estimates 351 
from a significant towards a non-significant result compared to multivariable models 352 
unadjusted for BMI (HR=0.98, 95% CI 0.89-1.09 vs HR=0.79, 95% CI 0.68-0.92) . This was 353 
similar to several previous studies [14, 15, 33, 37]. Some studies have found a statistically 354 
significant increased endometrial cancer risk in both inactive and active overweight women 355 
[11], which correspond to our findings. Others have shown an effect modification, where the 356 
inverse relationship was only seen among overweight or obese women [10, 37]. As in our 357 
study, several other studies have reported no significant effect modification for BMI [33, 12, 358 
16, 17, 31].  359 
Heterogeneity in different study results may be explained by variations in the methods 360 
used to assess PA (self-adminstered questionnaires, interviews, or use of job titles); PA 361 
domains (recreation, occupation, transportation, household); frequency, duration, and 362 
intensity of PA; and time periods in life when PA was measured, as well as different statistical 363 
methods used in the data analysis [40]. Nevertheless, there is substantial biological evidence 364 
to support a potential protective role of PA on endometrial cancer. The mechanisms involved 365 
have been hypothesized as affecting endogenous sex hormone levels, insulin-mediated 366 
pathways, and maintenance of energy balance [41]. 367 
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Physical inactivity is considered an important risk factor for different cancers [42-44]. The 368 
consistent associations between low PA levels and endometrial cancer risk  in our study 369 
justify the estimation of PAFs. Our definition of low PA levels was based on self-reported PA 370 
using a validated 10-point scale [21]. Our PAF estimation represents the minimum move 371 
required from low to higher levels of PA to create a significant change in the incidence of 372 
endometrial cancer (21.931%, 95% CI: 7.1-34.3). However, the definite dose cannot be 373 
quantified and our results must be interpreted with caution. , which corresponded to an 374 
increase in PA to 150 minutes of m derate/vigorous PA  per week. This amount is in 375 
accordance with World Health Organization Global Recommendations on PA for Health  . In 376 
the UK, Parkin found a PAF for endometrial cancer of 3.8% attributable to exercising less 377 
than the minimum recommended amount [43]. The proportion related to inadequate PA in the 378 
UK in 2002 was 30% for endometrial cancer, however that compared the highest (≥60 379 
minutes) and lowest (<30 minutes) PA levels, which gives a higher reference category than 380 
the recommendation of PA [45]. To quantify the PAF requires a realistic population 381 
distribution of the exposure of interest, which in our study is PA. We consider our cohort to 382 
be a nationally respresentative Norwegian cohort with a reliable population distribution of 383 
PA, and as such it should give a more robust estimate. Furthermore, it is valuable to evaluate 384 
the impact of different factors in cancer prevention, which is helpful in prioritizing cancer 385 
prevention and intervention strategies.   386 
A major strength of our study is its prospective, population-based design, and the use of a 387 
high-quality, nationally representative  cancer registryation system to identify endometrial 388 
cancer cases [20]. The large sample size and representativeness of the Norwegian female 389 
population 30 to 70 years of age gives a unique opportunity to calculate robust PAF estimates. 390 
The PA scale has been validated [21] and correlated well with all-cause mortality rates [46]. 391 
Furthermore, PA level, BMI, and smoking were re-assessed at follow-up. Self-reported BMI 392 
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has been validated for the NOWAC study, indicating that there was a substantial agreement 393 
between self-reported and measured BMI values [47]. There was, however, a small but 394 
statistically significant under-reporting of weight, which would affect self-reported BMI; this 395 
tendency was largest among overweight and obese women [20, 47] . A survey of the PA 396 
levels in the adult population in Norway showed that 34% of women reached the national 397 
guidelines for PA [48]. This proportion is higher than in our study. The relatively large 398 
number of cases made it possible to investigate subtypes of endometrial cancer, however the 399 
proportion of type 2 endometrial cancer was too low to allow for separate analyses. Multiple 400 
imputation of missing data, in addition to complete-case analysis, confirmed our results. The 401 
PA assessment in ourthis study comprised all areas of PA, not only recreational PA. However, 402 
the total self-reported measure of PA cannot differentiate intensity, duration, and frequency of 403 
PA, nor the type of PA in our study, and given the self report of PA, measurement errors 404 
cannot be ruled out. However, measurement errors would likely lead to a non-differential bias 405 
and a potential underestimation of the true effect. The PA assessment used in this study may 406 
not apply to women in other countries.  Moreover, the potential for residual confounding, in 407 
particular by BMI, remains. 408 
 409 
Conclusions  410 
Overall, we found an inverse dose-response association between PA and endometrial cancer 411 
with similar findings for subtypes of endometrial cancer. This risk was higher in obese 412 
women. Also, 21.931% of the endometrial cancer cases could bewere attributable to low 413 
levels of PA, and more than 1 in 4 cases could potentially be avoided if women attained a 414 
higher PA level. corresponding to 150 minutes per week or more.  415 
  416 
 417 
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Ethical approval: All procedures performed in studies involving human participants were in 418 
accordance with the ethical standards of the institutional and/or national research committee 419 
and with the 1964 Helsinki declaration and its later amendments or comparable ethical 420 
standards.  421 
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Table 1 Selected baseline characteristics of participants in the Norwegian Women and Cancer Study by physical activity level (n=82,759) 
 
Characteristic  Physical activity level 
1 to 4 N=21,953 (26.5%) 5 to 10 N=60,806 (73.5%) 
1 to 2 
N=3855 
(4.7%) 
3 to 4 
N=18,098 
(21.9%) 
5 to 6 
N=35,551 
(43.0%) 
7 to 8 
N=20,991 
(25.4%) 
9 to 10 
N=4264 
(5.2%) 
Age (mean, ±SE) 53.2 (.11) 52.1 (.05) 51.5 (.03) 51.3 (.04) 51.9 (.10) 
Person-years at risk 
1
 48 995 236 571 462 837 266 512 54 318 
Overall endometrial cancer (total cases n=687) 56 (8.2%) 181 (26.3%) 283 (41.2%) 139 (20.2%) 28 (4.1%) 
Endometrioid (total cases n=473 41 (8.7%) 134 (28.3%) 185 (39.1%) 100 (21.1%) 13 (2.7%) 
Type 1 endometrial cancer
2
 (total cases n=576) 47 (8.2%) 161 (28.0%) 226 (39.2%) 122 (21.2%) 20 (3.5%) 
Other subtypes
3
 (total cases n=111) 9 (8.1%) 20 (18%) 57 (51.4%) 17 (15.3%) 8 (7.2%) 












































































































Years of education (mean, ±SE) 11.5 (.06) 12.2 (.03) 12.3 (.02) 12.6 (.02) 11.9 (.06) 
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Missing (%) 6.6 5.2 4.5  4.9  6.0  






















































1Total person years=1,069,232; average follow-up time 12.92 years (SD=3.65) 
2Type 1 includes adenocarcinoma, endometrioid, squamous types  
3
Other subtypes are cases not equal to Type 1 
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Table 2 Relative risk estimates of endometrial cancer (overall, type 1, and endometrioid) by physical activity (PA) level at baseline and 
follow-up in the Norwegian Women and Cancer Study (n=82 759)  
 Endometrial 






Crude n=687  1.73 (1.30-2.31) 1.21 (1.00-1.46) 1.00 0.87 (0.71-1.07) 0.83 (0.56-1.22) 0.00 
PA + BMI n= 673 1.47 (1.09-1.97) 1.09 (0.9-1.32) 1.00 0.91 (0.74-1.11) 0.86 (0.58-1.27) 0.01 
Multivariable  
without BMI n=607 1.85 (1.36-2.53) 1.28 (1.05-1.56) 1.00 0.89 (0.72-1.11) 0.71 (0.45-1.12) 0.00 
Multivariable n=593  1.60 (1.16-2.20) 1.15 (0.94-1.41) 1.00 0.92 (0.74-1.15) 0.73 (0.45-1.16) 0.01 




Crude n=576  1.83 (1.33-2.51) 1.35 (1.10-1.65) 1.00 0.96 (0.77-1.19) 0.74 (0.47-1.17) 0.00 
PA + BMI n=564 1.51 (1.10-2.09) 1.20 (0.97-1.47) 1.00 1.01 (0.81-1.26) 0.76 (0.48-1.22) 0.01 
Multivariable  
without BMI n=510 1.97 (1.4-2.78) 1.47 (1.19-1.82) 1.00 1.00 (0.79-1.26) 0.68 (0.4-1.15) 0.00 
Multivariable n=498 1.66 (1.17-2.36) 1.31 (1.05-1.63) 1.00 1.04 (0.82-1.32) 0.69 (0.40-1.18) 0.00 
        
Endometrioid 
subtype 
Crude n=473  1.96 (1.39-2.75) 1.37 (1.10-1.72) 1.00 0.96 (0.75-1.22) 0.59 (0.33-1.03) 0.00 
PA + BMI n=463 1.59 (1.12-2.25) 1.20 (0.96-1.51) 1.00 1.00 (0.79-1.29) 0.59 (0.33-1.06) 0.004 
Multivariable  
without BMI n=428 2.25 (1.57-3.22) 1.51 (1.2-1.91) 1.00 1.01 (0.78-1.3) 0.61 (0.33-1.13) 0.00 
Multivariable n=418 1.83 (1.26-2.64) 1.32 (1.04-1.67) 1.00 1.06 (0.82-1.37) 0.60 (0.32-1.15) 0.001 







Crude n= 450 1.78 (1.22-2.58) 1.31 (1.04-1.65) 1.00 0.86 (0.67-1.10) 0.87 (0.54-1.40) 0.00 
PA + BMI n=438 1.48 (1.01-2.17) 1.18 (0.93-1.49)  0.91 (0.71-1.17) 0.98 (0.61-1.57) 0.04 
Multivariable 
without BMI n=393 1.80 (1.19-2.72) 1.35 (1.06-1.73) 1.00 0.92 (0.71-1.2) 0.71 (0.4-1.26) 0.00 
Multivariable n=381 1.54 (1.01-2.35) 1.22 (0.95-1.58) 1.00 0.97 (0.74-1.26) 0.80 (0.45-1.41) 0.02 
        
Type 1 
Crude n = 387  1.98 (1.34-2.91) 1.39 (1.09-1.78) 1.00 0.83 (0.63-1.09) 0.93 (0.56-1.53) 0.00 
PA + BMI n=377 1.60 (1.08-2.39) 1.25 (0.97-1.61) 1.00 0.88 (0.67-1.17) 1.06 (0.64-1.75) 0.01 
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without BMI n=337 2.10 (1.38-3.21) 1.46 (1.12-1.9) 1.00 0.94 (0.71-1.25) 0.8 (0.44-1.45) 0.00 
Multivariable n=327 1.75 (1.13-2.71) 1.33 (1.01-1.74) 1.00 0.99 (0.74-1.33) 0.91 (0.5-1.65) 0.01 
        
Endometrioid 
Crude n = 321  1.90 (1.24-2.89) 1.30 (1.00-1.70) 1.00 0.72 (0.53-0.97) 0.61 (0.32-1.16) 0.00 
PA + BMI n=311 1.55 (1.00-2.39) 1.18 (0.9-1.55) 1.00 0.76 (0.55-1.03) 0.7 (0.37-1.34) 0.01 
Multivariable 
without BMI n=290 2.15 (1.38-3.34) 1.34 (1.01-1.79) 1.00 0.78 (0.57-1.07) 0.65 (0.33-1.28) 0.00 
Multivariable n=280 1.77 (1.12-2.81) 1.22 (0.91-1.63) 1.00 0.82 (0.60-1.14) 0.75 (0.38-1.49) 0.01 
 
1 
Crude model with age as time-variable.  
2 Model with adjustment for BMI. 
3Multivariable model adjusted for use of hormone therapy, oral contraceptive use, years of education, smoking, alcohol consumption (gram per day).  
4
Multivariable model same as above, but with adjustments for BMI included. 
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Table 3 Relative risk estimates of overall endometrial cancer by physical activity (PA) level at baseline and follow-up according to body 
mass index (BMI) status at baseline in the Norwegian Women and Cancer study (n=82,759) 
Complete 





Normal BMI n=318 1.28 (0.74-2.21) 1.06 (0.79-1.42) 1.00 0.83 (0.64-1.07) 0.10 
Overweight n=234 1.04 (0.60-1.83) 1.02 (0.75-1.39) 1.00 0.90 (0.64-1.26) 0.66 
Obese n=121 2.50 (1.49-4.20) 1.45 (0.92-2.29) 1.00 1.32 (0.74-2.36) 0.01 
       
Multivariable 
Normal BMI n=281 1.32 (0.71-2.45) 1.19 (0.87-1.62) 1.00 0.86 (0.66-1.14) 0.07 
Overweight n=212 0.95 (0.51-1.77) 1.00 (0.73-1.39) 1.00 0.90 (0.63-1.28) 0.76 
Obese n=100 3.08 (1.76-5.39) 1.55 (0.93-2.56) 1.00 0.98 (0.48-1.99) 0.00 






Normal BMI n=182 1.26 (0.58-2.73) 0.85 (0.56-1.30) 1.00 0.80 (0.58-1.12) 0.39 
Overweight n=169 1.44 (0.74-2.82) 1.39 (0.97-2.01) 1.00 1.16 (0.78-1.71) 0.61 
Obese n=87 1.78 (0.94-3.37) 1.39 (0.84-2.30) 1.00 0.73 (0.34-1.56) 0.01 
       
Multivariable 
Normal BMI n=164 1.17 (0.47-2.91) 0.90 (0.58-1.41) 1.00 0.86 (0.61-1.21) 0.53 
Overweight n=147 1.15 (0.52-2.53) 1.35 (0.92-2.00) 1.00 1.17 (0.78-1.77) 0.81 
Obese n=70 2.45 (1.22-4.91) 1.63 (0.92-2.89) 1.00 0.56 (0.21-1.50) 0.00 
1 
Crude model with age as time-variable. 
2 Multivariable model adjusted for use of hormone therapy, oral contraceptive use, years of education, smoking, alcohol consumption (gram/day).  
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Table 4: Relative risk estimates of endometrial cancer (overall, type 1 and endometrioid) by physical activity (PA) level at baseline and 




 1 to 2 3 to 4 5 to 6 7 to 8 9 to 10 p_trend 
Overall 
Crude n=687  1.76 (1.27-2.44) 1.34 (1.09-1.65) 1.00 0.80 (0.65-1.00) 0.73 (0.48-1.12) 0.00 
PA + BMI n= 687 1.47 (1.05-2.05) 1.22 (0.98-1.50) 1.00 0.85 (0.69-1.06) 0.80 (0.52-1.22) 0.001 
Multivariable  
without BMI n=687 1.87 (1.32-2.63) 1.40 (1.13-1.74) 1.00 0.85 (0.69-1.07) 0.71 (0.45-1.13) 0.02 
Multivariable n=687  1.58 (1.11-2.24) 1.28 (1.02-1.59) 1.00 0.90 (0.72-1.13) 0.78 (0.49-1.22) 0.02 
        
Type 1 
Crude n=576 1.87 (1.23-2.83) 1.30 (1.00-1.70) 1.00 0.71 (0.53-0.96) 0.60 (0.31-1.14) 0.00 
PA + BMI n= 576 1.51 (0.99-2.31) 1.16 (0.89-1.52) 1.00 0.77 (0.57-1.04) 0.67 (0.35-1.27) 0.001 
Multivariable  
without BMI n=576 2.05 (1.34-3.15) 1.34 (1.02-1.77) 1.00 0.77 (0.57-1.05) 0.66 (0.35-1.27) 0.00 
Multivariable n=576  1.66 (1.08-2.57) 1.19 (0.90-1.58) 1.00 0.83 (0.61-1.13) 0.74 (0.39-1.42) 0.002 
        
 Crude n=473 1.89 (1.28-2.79) 1.45 (1.13-1.85) 1.00 0.76 (0.58-0.99) 0.48 (0.24-0.96) 0.00 
Endometrioid PA + BMI n= 473 1.51 (1.01-2.26) 1.28 (1.00-1.64) 1.00 0.82 (0.63-1.07) 0.54 (0.27-1.08) 0.01 
 
Multivariable  
without BMI n=473 2.11 (1.42-3.14) 1.53 (1.18-1.97) 1.00 0.83 (0.63-1.09) 0.54 (0.27-1.07) 0.00 
 Multivariable n=473  1.70 (1.13-2.56) 1.35 (1.05-1.75) 1.00 0.89 (0.68-1.17) 0.60 (0.30-1.20) 0.00 
1 
Crude model with age as time-variable.  
2
 Model with adjustment for BMI. 
3Multivariable model adjusted for use of hormone therapy, oral contraceptive use, years of education, smoking, alcohol consumption (gram per day).  
4Multivariable model same as above, but with adjustment for BMI included. 
BMI: body mass index
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Table 5: Population attributable fraction (PAF) for the proportion of endometrial cancer in the population that would be avoided if low 
physical activity (PA) level increased 
 
  Overall 
  Model 1
1
 n= 673 Model 2
2
 n= 593 
PA level Pe PAF PAF 95% CI RR= 95% CI PAF PAF 95% CI RR= 95% CI 
[1-4] to [5-10] 26.5 % 17% [2.3-29.5] 1.21 [1.02-1.42] 21.9%    [7.1-34.3] 1.28 [1.08-1.52] 
1Model 1: measured at baseline with age as time variable and adjusted for BMI.  
2
Model 2: Measured at baseline in a multivariable model adjusted for BMI, oral contraceptive use, hormone therapy use, years of education, smoking status, and alcohol 
consumption (grams per day). 
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